Skip to main content
. 2016 May 24;7(26):40200–40220. doi: 10.18632/oncotarget.9571
Primary therapy outcome success
Prognostic risk Complete response Partial response Progressive and stable disease
low 82 4 11
intermediate 88 33 32
high 13 10 3

Kappa coefficient = 0.183

Kappa p-value = 0.00104